STRS Ohio’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-88,500
Closed -$793K 2063
2016
Q3
$793K Buy
+88,500
New +$629K ﹤0.01% 941
2015
Q4
Sell
-3,400
Closed -$20K 2036
2015
Q3
$20K Buy
+3,400
New +$41.7K ﹤0.01% 1824
2014
Q2
Sell
-21,300
Closed -$213K 1886
2014
Q1
$213K Buy
+21,300
New +$308K ﹤0.01% 1427

STRS Ohio's RPTP Position: Q4 2016 in Review

STRS Ohio sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 88,500 shares — an estimated $793K sold.

STRS Ohio first reported a position in RPTP in Q1 2014 and held it in 3 quarters. The position peaked at $793K in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • STRS Ohio reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • STRS Ohio sold 88,500 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $793K.
  • STRS Ohio first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q1 2014 and held it in 3 quarters.
  • STRS Ohio's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $793K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on STRS Ohio's 13F filing for Q4 2016, filed 24 Jan 2017.